Ranitidine Market Witness an Outstanding Growth and Strong Revenue by 2027 | Grand Health Industrial Co ltd., Zydus Cadila, Granuals India

The global Ranitidine market is expected to reach US$ 494.3 Million by 2027, with a CAGR of 2.4% from 2021 to 2027. Ranitidine, sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein. In September 2019, the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products from a number of manufacturers, resulting in recalls.

Common side effects include headaches and pain or burning if given by injection. Serious side effects may include liver problems, a slow heart rate, pneumonia, and the potential of masking stomach cancer. It is also linked to an increased risk of Clostridium difficile colitis. It is generally safe in pregnancy. Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine, thus decreasing the amount of acid released by cells of the stomach.

Get FREE Sample Copy of Ranitidine Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=667089

Top Key Players Included in Ranitidine Market Report: Grand Health Industrial Co ltd., Zydus Cadila, Granuals India, Glenmark Generics Inc., Geneva Pharmaceuticals, Novitium Pharma, Ajanta Pharma, Vivimed Global, Aurobindo Pharma Ltd

Because of the lockdowns imposed in the majority of countries, the COVID-19 pandemic appears to have impacted product demand in the Ranitidine industry in recent months. Since the epidemic, these lockdowns have resulted in a temporary halt in output. Several countries faced curfew-like situations in which businesses were not authorised to operate except for vital services, reducing demand for Ranitidine.

Get Discount on Ranitidine Market Report: https://www.infinitybusinessinsights.com/ask_for_discount.php?id=667089

Ranitidine Market segment by Type:
Tablet
Syrup
Injectable solution
Others

Ranitidine Market segment by Application:
Stomach and intestine ulcers
Erosive esophagitis
Gastroesophageal reflux disease
Zollinger Ellison syndrome
Others

The Ranitidine market study looks at the industry in terms of countries and regions, type and application, and main market participants. The market is divided into many regions, including Latin America, North America, Europe, Asia Pacific, and Africa. These variables are then further split into the nations that comprise the major geographical regions.

FAQs:
1. What will be the normal portion of the overall industry for impending years?
2. What are the moving and arising advances expected to influence the advancement of the worldwide Ranitidine market?
3. What are the Ranitidine market’s developing regions?
4. What are the market opportunities and threats faced by the vendors in the Ranitidine market?

For More Information: https://www.infinitybusinessinsights.com/enquiry_before_buying.php?id=667089

Contact us:
Amit J
Sales Co-Ordinator
International: +1-518-300-3575
Email: inquiry@infinitybusinessinsights.com
Website: https://www.infinitybusinessinsights.com
Facebook: https://facebook.com/Infinity-Business-Insights-352172809160429
LinkedIn: https://www.linkedin.com/company/infinity-business-insights
Twitter: https://twitter.com/IBInsightsLLP

About Us:
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

This release was published on openPR.